Search Results
Apr 13, 2026, 20:00 ET Kelun-Biotech Announces Results from the SKB264-II-06/MK-2870-002 Study of Sacituzumab Tirumotecan (Sac-TMT) in Gynecologic Oncology Presented at 2026 SGO
presentation at the 2026 Society of Gynecologic Oncology (SGO) Annual Meeting in San Juan, Puerto Rico. The data were presented by Professor Xiaohua Wu of Fudan University Shanghai Cancer Center.
More news about: Kelun-Biotech
Apr 13, 2026, 06:45 ET Lilly's Jaypirca (pirtobrutinib) significantly extended progression-free survival when added to a venetoclax time-limited regimen in patients with previously treated CLL/SLL
therapies in mantle cell lymphoma. J Hematol Oncol. 2020;13(1):79. Published 2020 Jun 17. doi:10.1186/s13045-020-00914-1Gu D, Tang H, Wu J, Li J, Miao Y. Targeting Bruton tyrosine kinase using non-covalent inhibitors in B cell malignancies. J Hematol Oncol. 2021;14(1):40. Published
More news about: Eli Lilly and Company
Apr 10, 2026, 09:00 ET Farmers' Special Bus Line: Connecting hearts, bringing closeness
shopping disguised as an ordinary citizen and is recognized, it is normally just another trivial entertainment news story. Yet recently, when Wu Kequn (Kenji Wu), a singer from Taiwan, China, quietly visited a vegetable stall in Guiyang, and was warmly welcomed by local farmer-vendors as if he were one
More news about: China.org.cn
Apr 10, 2026, 07:48 ET EX.IO Partners with Payment Asia, Joining Hands to Support Hong Kong's Licensed Stablecoin Ecosystem
(RWA) scenarios, seizing the tremendous opportunities presented by the explosive growth of Hong Kong's licensed stablecoin ecosystem.Ms. Chen Wu, Co-founder and Chief Executive Officer of EX.IO, stated:"The issuance of Hong Kong's inaugural licensed stablecoin marks a significant and
More news about: Payment Asia
Apr 10, 2026, 07:44 ET EX.IO Partners with Payment Asia, Joining Hands to Support Hong Kong's Licensed Stablecoin Ecosystem
(RWA) scenarios, seizing the tremendous opportunities presented by the explosive growth of Hong Kong's licensed stablecoin ecosystem.Ms. Chen Wu, Co-founder and Chief Executive Officer of EX.IO, stated:"The issuance of Hong Kong's inaugural licensed stablecoin marks a significant and
More news about: Payment Asia
Apr 10, 2026, 07:16 ET BD introduce un'innovazione TIPS di nuova generazione per migliorare il trattamento dell'ipertensione portale in tutta l'Unione Europea
@becton_dickinson.________________________________1 Duo H, You J, Du S, Yu M, Wu S, Yue P, et al. Liver cirrhosis in 2021: Global Burden of Disease study. PLOS One. 2025;20(7):e0328493. doi: 10.1371/journal.pone.0328492 Carroll
More news about: BD (Becton, Dickinson and Company)
Apr 09, 2026, 20:00 ET AI Pioneer and Nobel Laureate Geoffrey Hinton Joins Human Longevity, Inc. Scientific Advisory Board
genomics, advanced imaging, and multi-omic biomarkers."We are deeply honored to welcome Dr. Hinton as an advisor to Human Longevity," said Dr. Wei-Wu He, Executive Chairman of HLI. "Artificial intelligence is at the core of everything we do. I firmly believe AI will transform healthcare, and Dr. Hinton's
More news about: Human Longevity Inc.
Apr 09, 2026, 13:04 ET The Misty Copeland Foundation to Host Spring Benefit Honoring Misty Copeland's Legacy
Misty Copeland Foundation gratefully acknowledges the leadership support of its Diamond Sponsors, The Arnhold Family, Sarah Arison, and Clara Wu Tsai and the New York Liberty and its Platinum Sponsors, Nyssa and Chris Lee and Ann and Weston Hicks, whose generosity helps sustain and
More news about: The Misty Copeland Foundation
Apr 09, 2026, 13:00 ET What If You're Not Defined by Your Worst Moment?
best-selling author Lisa Feldman Barrett, PhD, neuroscientist and NYU Dean Wendy Suzuki, PhD, futures designer Nick Foster, RDI, sleep psychologist Jade Wu, PhD, broadcaster and author Krista Tippett, journalist and author Eliot Stein, and medical anthropologist and author Theresa MacPhail, PhD.
More news about: Unlikely Collaborators
Apr 09, 2026, 09:00 ET Kindsight appoints Chief Community Officer to expand its community programming and investment
George Wu as its first Chief Community Officer, part of its expanded investment in holistic community support and programming. This strategic focus solidifies
More news about: Kindsight
Apr 09, 2026, 09:00 ET Kindsight appoints Chief Community Officer to expand its community programming and investment
George Wu as its first Chief Community Officer, part of its expanded investment in holistic community support and programming. This strategic focus solidifies
More news about: Kindsight
Apr 09, 2026, 08:35 ET Global Buyers Boost China Sourcing by 25% During Made-in-China.com's "Amazing April," Signaling 2026 Procurement Trends
overseas buyers, and providing one-stop services for promoting the international trade between the two sides.Media Contact:Yichun Wu[email protected]
More news about: Made-in-China.com
Apr 08, 2026, 09:15 ET Manulife John Hancock Investments Launches New Active Hedged Equity ETF
fundamental equity selection and a dynamic options overlay. Manulife IM portfolio managers, Michael J. Scanlon, Jr. CFA, Pierre Micallef, CFA, and Jeffrey Wu are primarily responsible for the management of the fund's portfolio. The strategy has been managed by Manulife IM (US) since 2020, and this new ETF
More news about: Manulife Wealth & Asset Management
Apr 08, 2026, 06:50 ET BD Delivers Next‑Generation TIPS Innovation to Advance Portal Hypertension Care Across the European Union
@becton_dickinson.________________________________1 Duo H, You J, Du S, Yu M, Wu S, Yue P, et al. Liver cirrhosis in 2021: Global Burden of Disease study. PLOS One. 2025;20(7):e0328493. doi: 10.1371/journal.pone.0328492 Carroll
More news about: BD (Becton, Dickinson and Company)
Apr 08, 2026, 06:50 ET BD Delivers Next‑Generation TIPS Innovation to Advance Portal Hypertension Care Across the European Union
@becton_dickinson.________________________________1 Duo H, You J, Du S, Yu M, Wu S, Yue P, et al. Liver cirrhosis in 2021: Global Burden of Disease study. PLOS One. 2025;20(7):e0328493. doi: 10.1371/journal.pone.0328492 Carroll
More news about: BD (Becton, Dickinson and Company)
Apr 08, 2026, 06:50 ET BD stellt die nächste Generation der TIPS-Technologie vor, um die Behandlung der portalen Hypertonie in der gesamten Europäischen Union voranzubringen
@becton_dickinson.________________________________1 Duo H, You J, Du S, Yu M, Wu S, Yue P, et al. Liver cirrhosis in 2021: Global Burden of Disease Studie. PLOS One. 2025;20(7):e0328493. doi: 10.1371/journal.pone.0328492 Carroll
More news about: BD (Becton, Dickinson and Company)
Apr 08, 2026, 06:50 ET BD ofrece la tecnología TIPS para impulsar la atención de la hipertensión portal en toda la Unión Europea
@becton_dickinson.________________________________1 Duo H, You J, Du S, Yu M, Wu S, Yue P, et al. Liver cirrhosis in 2021: Global Burden of Disease study. PLOS One. 2025;20(7):e0328493. doi: 10.1371/journal.pone.0328492 Carroll
More news about: BD (Becton, Dickinson and Company)
Apr 08, 2026, 06:50 ET BD propose une innovation TIPS de nouvelle génération pour faire progresser les soins de l'hypertension portale dans l'Union européenne
@becton_dickinson.________________________________1 Duo H, You J, Du S, Yu M, Wu S, Yue P, et al. Liver cirrhosis in 2021: Global Burden of Disease study. PLOS One. 2025;20(7):e0328493. doi: 10.1371/journal.pone.0328492 Carroll
More news about: BD (Becton, Dickinson and Company)
Apr 07, 2026, 07:00 ET Ascletis Announces Fixed-Dose Combination of ASC30, Once-Daily Oral Small Molecule GLP-1R Agonist, and ASC39, Once-Daily Oral Small Molecule Amylin-Selective Amylin Receptor Agonist, for Clinical Development
important step in the development of a new oral, potentially synergistic combination of ASC30 and ASC39 for the treatment of obesity," said Jinzi Jason Wu, Ph.D., Founder, Chairman and CEO of Ascletis. "We believe this fixed dose combination, which combines the key features of high bioavailability, high
More news about: Ascletis Pharma Inc.
Apr 06, 2026, 17:39 ET DataBeyond dévoile le plus grand centre de tri IA sans personnel d'Asie, établissant une nouvelle référence en matière d'économie circulaire
d'exceller dans l'utilisation de celui-ci, accélérant ainsi la transition mondiale vers une ère de recyclage intelligent.Contact : YI WU[email protected] +86 18038378718Photo -
More news about: Hangzhou DataBeyond Technology Co., Ltd.
Apr 06, 2026, 09:22 ET DataBeyond stellt Asiens größtes unbemanntes KI-Sortierzentrum vor und setzt damit einen neuen Maßstab für die Kreislaufwirtschaft
jetzt High-End-Geräte leisten – so beschleunigen sie den globalen Übergang zu einer Ära des intelligenten Recyclings.Kontakt: YI WU[email protected] +86 18038378718Foto:
More news about: Hangzhou DataBeyond Technology Co., Ltd.
Apr 06, 2026, 09:00 ET Abbott recebe aprovação regulatória no Brasil de serplulimabe, novo medicamento biológico para o tratamento de câncer de pulmão de pequenas células com doença extensa, oferecendo uma nova alternativa para pacientes
file.Cheng Y, Han L, Wu L, et al. Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer: The ASTRUM-005 Randomized Clinical Trial. JAMA. 2022;328(12):1223-1232. doi: 10.1001/jama.2022.16464Cheng Y, Han, L, Wu L, et al. Serplulimab
More news about: Abbott
Apr 06, 2026, 07:42 ET DataBeyond presenta el mayor centro de clasificación automatizado con IA de Asia
equipos de alta gama y destacar en su uso, acelerando la transición global hacia una era de reciclaje inteligente.Contacto: YI WU[email protected] +86 18038378718Foto
More news about: Hangzhou DataBeyond Technology Co., Ltd.
Apr 06, 2026, 06:13 ET DataBeyond Unveils Asia's Largest Unmanned AI Sorting Center, Setting a New Circular Economy Benchmark
"afford and excel" in using high-end equipment, accelerating the global transition to an intelligent recycling era.Contact: YI WU[email protected] +86 18038378718Photo -
More news about: Hangzhou DataBeyond Technology Co., Ltd.
Apr 06, 2026, 06:03 ET DataBeyond Unveils Asia's Largest Unmanned AI Sorting Center, Setting a New Circular Economy Benchmark
"afford and excel" in using high-end equipment, accelerating the global transition to an intelligent recycling era.Contact: YI WU[email protected] +86 18038378718
More news about: Hangzhou DataBeyond Technology Co., Ltd.